Insights On Enterprise Solutions

  1. Simtra Capabilities Update April 2026: Fill/Finish 4/28/2026

    A look at sterile injectable expansion highlighting investment, advanced fill‑finish technologies, and flexible manufacturing from development to commercial production.

  2. Bora Pharmaceuticals Capabilities Update April 2026: Small Molecule Drug Product 4/28/2026

    Bora Pharmaceuticals is a global CDMO specializing in small molecule drug product development and manufacturing from clinical through commercial supply.

  3. Kindeva Capabilities Update April 2026: Fill/ Finish 4/28/2026

    An overview of sterile fill‑finish capabilities showcasing automated aseptic technologies, scalable capacity, and collaborative approaches for efficient, reliable injectable supply.

  4. August BioServices Capabilities Update April 2026: Fill/Finish 4/28/2026

    A U.S.-based sterile injectable CDMO delivering scalable small and large molecule manufacturing, supported by advanced aseptic technologies, integrated quality systems, and commercial-ready capabilities.

  5. Strengthening Drug Product CMC through Drug Product Science | AAPS 4/27/2026

    At AAPS, drug product experts discuss how formulation, stability, and analytical services enable robust CMC strategies, reduce development risk, and support confident regulatory decision‑making.

  6. Using Tech Transfer To Accelerate NDA Approval 4/27/2026

    A biotech company accelerated NDA approval for a novel anti‑infective by executing a highly disciplined, first‑time‑right technology transfer and registration batch manufacturing strategy.

  7. Biologics Tech Transfer & Validation at Scale: A Better Path to GMP 4/24/2026

    Explore where tech transfer and validation commonly falter, and how disciplined execution helps teams maintain control through PPQ and beyond.

  8. ESACT 2026: Reducing Variability With Animal‑Origin‑Free Peptones 4/24/2026

    Explore how data‑driven collaboration and animal‑origin‑free media strategies can reduce variability, improve cell culture performance, and support consistent, cost‑effective bioprocessing at scale.

  9. Stability With IDBS Polar 4/24/2026

    Manual tracking often leads to missed pulls and data gaps. Discover how a connected digital workflow governs stability execution, ensuring consistency and regulatory confidence at every timepoint.

  10. Managing CMC Risk For Complex Peptide And Nucleic Acid Therapeutics 4/24/2026

    At TIDES USA 2026, experts discuss how formulation science, stability strategies, and advanced analytics help reduce CMC risk and enable confident development of peptide and nucleic acid therapeutics.